Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients.
breast cancer
ca 15-3
fibroadenoma
luminal a subtype
luminal b her2-negative subtype
mmp-3
mmp-7
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Mar 2023
30 Mar 2023
Historique:
received:
24
02
2023
revised:
17
03
2023
accepted:
28
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Matrix metalloproteinases (MMPs) are a group of enzymes that mediate both physiological and pathological processes such as carcinogenesis. The role of matrix metalloproteinase-3 (MMP-3) and (MMP-7) in the pathogenesis of breast cancer (BC) has been demonstrated, suggesting that they may be considered as potential markers of this condition. The aim of this study was to assess plasma concentrations and diagnostic utility of MMP-3 and MMP-7 in 100 patients with early-stage breast cancer with Luminal A subtype or Luminal B HER-negative subtype, before and after surgical treatment, and in the following control groups: patients with a benign tumor (
Identifiants
pubmed: 37048701
pii: jcm12072618
doi: 10.3390/jcm12072618
pmc: PMC10094779
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Oncol. 2008 Sep;19(9):1566-72
pubmed: 18503039
Int J Mol Sci. 2021 Dec 23;23(1):
pubmed: 35008569
Cancers (Basel). 2022 Sep 01;14(17):
pubmed: 36077812
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Med Oncol. 2008;25(3):279-83
pubmed: 18071928
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Hum Pathol. 1999 Apr;30(4):436-42
pubmed: 10208466
BMC Cancer. 2011 Aug 11;11:348
pubmed: 21835023
Clin Biochem. 2011 Jul;44(10-11):869-72
pubmed: 21565179
BMC Cancer. 2008 Mar 28;8:83
pubmed: 18373849
Cancer Control. 2021 Jan-Dec;28:10732748211033743
pubmed: 34482737
Asian Pac J Cancer Prev. 2013;14(3):1615-21
pubmed: 23679245
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:3-6
pubmed: 20711654
PLoS One. 2013 Oct 15;8(10):e77425
pubmed: 24143235
Med Oncol. 2010 Dec;27(4):1246-53
pubmed: 19937162
J Ovarian Res. 2018 Jan 5;11(1):1
pubmed: 29304854
Eur J Cancer Prev. 2014 Sep;23(5):336-43
pubmed: 24999605
Int J Mol Sci. 2021 Aug 20;22(16):
pubmed: 34445715
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jul;43(4):406-12
pubmed: 25187454
BMC Cancer. 2009 Jun 16;9:188
pubmed: 19531263
Oncotarget. 2015 Jun 20;6(17):15164-79
pubmed: 26008967
Genes Cancer. 2015 Nov;6(11-12):480-9
pubmed: 26807201
Mech Ageing Dev. 2011 May;132(5):213-9
pubmed: 21507328
J Clin Med. 2022 Nov 12;11(22):
pubmed: 36431173
J Clin Med. 2021 Nov 22;10(22):
pubmed: 34830735
Hum Pathol. 2016 Jan;47(1):104-8
pubmed: 26520416
J Ovarian Res. 2017 Jun 29;10(1):39
pubmed: 28662671
Breast Dis. 2017;37(2):63-68
pubmed: 28655117
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916127
Ai Zheng. 2006 Mar;25(3):315-9
pubmed: 16536985
Onco Targets Ther. 2018 Jul 20;11:4207-4220
pubmed: 30050312
Breast Cancer Res Treat. 2014 Jul;146(1):25-40
pubmed: 24847890
Breast Cancer Res Treat. 2014 Oct;147(3):609-16
pubmed: 25164974
Mol Biol Rep. 2020 Dec;47(12):9637-9644
pubmed: 33170424
Cancer Manag Res. 2020 Oct 30;12:10949-10964
pubmed: 33154674
Int J Cancer. 2006 Sep 15;119(6):1403-11
pubmed: 16615109
Dis Markers. 2013;34(6):395-405
pubmed: 23568046
Biomark Med. 2020 Jul;14(11):997-1007
pubmed: 32940077
Histopathology. 2008 Oct;53(4):403-15
pubmed: 18983606
Front Genet. 2022 Jan 06;12:809600
pubmed: 35069702
PLoS One. 2013 May 16;8(5):e63165
pubmed: 23696797
Clin Cancer Res. 2005 Aug 15;11(16):6012-9
pubmed: 16115946
Anticancer Res. 2007 Jan-Feb;27(1A):95-105
pubmed: 17352221
Breast. 2013 Jun;22(3):330-4
pubmed: 22995648
Breast Cancer Res Treat. 2018 May;169(1):141-152
pubmed: 29353367
BMC Cancer. 2014 Dec 16;14:959
pubmed: 25510449
Clin Chim Acta. 2010 Dec 14;411(23-24):1869-74
pubmed: 20816948
PLoS One. 2017 Sep 29;12(9):e0184448
pubmed: 28961241
Cancer Causes Control. 2014 Dec;25(12):1717-23
pubmed: 25225035
Mol Aspects Med. 2008 Oct;29(5):290-308
pubmed: 18619669
J Breast Cancer. 2020 Feb 18;23(1):1-9
pubmed: 32140265
Bull Exp Biol Med. 2011 Jul;151(3):359-62
pubmed: 22451887
Anat Rec (Hoboken). 2020 Jun;303(6):1557-1572
pubmed: 31168956
J Cell Mol Med. 2020 Jan;24(1):139-148
pubmed: 31568637